Role of HDL function and LDL atherogenicity on cardiovascular risk: a comprehensive examination
Visualitza/Obre
Autor/a
Hernáez, Álvaro
Soria Florido, María Trinidad
Schröder, Helmut, 1958-
Ros Rahola, Emilio
Pintó Sala, Xavier
Estruch Riba, Ramon
Salas Salvadó, Jordi
Corella Piquer, Dolores
Arós, Fernando
Serra Majem, Lluís
Martínez-González, Miguel Ángel, 1957-
Fiol Sala, Miguel
Lapetra, José
Elosua Llanos, Roberto
Lamuela Raventós, Rosa Ma.
Fitó Colomer, Montserrat
Altres autors/es
Universitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
Data de publicació
2019-06Resum
Background
High-density lipoprotein (HDL) functionality and low-density lipoprotein (LDL) atherogenic traits can describe the role of both particles on cardiovascular diseases more accurately than HDL- or LDL-cholesterol levels. However, it is unclear how these lipoprotein properties are particularly affected by different cardiovascular risk factors.
Objective
To determine which lipoprotein properties are associated with greater cardiovascular risk scores and each cardiovascular risk factor.
Methods
In two cross-sectional baseline samples of PREDIMED trial volunteers, we assessed the associations of HDL functionality (N = 296) and LDL atherogenicity traits (N = 210) with: 1) the 10-year predicted coronary risk (according to the Framingham-REGICOR score), and 2) classical cardiovascular risk factors.
Results
Greater cardiovascular risk scores were associated with low cholesterol efflux values; oxidized, triglyceride-rich, small HDL particles; and small LDLs with low resistance against oxidation (P-trend<0.05, all). After adjusting for the rest of risk factors; 1) type-2 diabetic individuals presented smaller and more oxidized LDLs (P<0.026, all); 2) dyslipidemic participants had smaller HDLs with an impaired capacity to metabolize cholesterol (P<0.035, all); 3) high body mass index values were associated to lower HDL and LDL size and a lower HDL capacity to esterify cholesterol (P<0.037, all); 4) men presented a greater HDL oxidation and lower HDL vasodilatory capacity (P<0.046, all); and 5) greater ages were related to small, oxidized, cytotoxic LDL particles (P<0.037, all).
Conclusions
Dysfunctional HDL and atherogenic LDL particles are present in high cardiovascular risk patients. Dyslipidemia and male sex are predominantly linked to HDL dysfunctionality, whilst diabetes and advanced age are associated with LDL atherogenicity.
Tipus de document
Article
Versió publicada
Llengua
English
Matèries (CDU)
616.1 - Patologia del sistema circulatori, dels vasos sanguinis. Trastorns cardiovasculars
Paraules clau
Sistema cardiovascular -- Malalties -- Factors de risc
Lipoproteïnes de densitat alta
Lipoproteïnes de densitat baixa
Colesterol
Pàgines
15 p.
Publicat per
Public Library of Science (PLoS)
Publicat a
PLoS One, 2019, vol. 14, núm. 6: e0218533
Aquest element apareix en la col·lecció o col·leccions següent(s)
Drets
© L'autor/a
Excepte que s'indiqui una altra cosa, la llicència de l'ítem es descriu com http://creativecommons.org/licenses/by/4.0/